Use of Genetically Engineered Biological Drugs for Rheumatoid Arthritis in the Russian Federation

Nauchno-Prakticheskaya Revmatologiya - Russian Federation
doi 10.14412/1995-4484-2012-1286
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Rheumatoid Arthritis Therapy With Genetically Engineered Biological Agents in the Republic of Karelia

Modern Rheumatology Journal
2013English

Some Aspects of the Use of Genetically Engineered Biological Products for the Treatment of Psoriasis

2019English

Anti-Inflammatory Drugs for Rheumatoid Arthritis

BMJ
1976English

Biological Detoxification of the Mycotoxin Deoxynivalenol and Its Use in Genetically Engineered Crops and Feed Additives

Applied Microbiology and Biotechnology
Applied MicrobiologyBiotechnologyMedicine
2011English

Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983-2009

Arthritis Care and Research
Rheumatology
2013English

Biological Targets in the Treatment of Rheumatoid Arthritis: A Comprehensive Review of Current and In-Development Biological Disease Modifying Anti-Rheumatic Drugs

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Tenage Pregnancy Medical and Biological Problems in Russian Federation

2017English

Virtual Screening of Natural Metabolites as Candidate Drugs for Rheumatoid Arthritis

International Journal of Recent Technology and Engineering
EngineeringManagement of TechnologyInnovation
2020English

Prescription Practice of Biological Drugs in Rheumatoid Arthritis During the First 3 Years of Post-Marketing Use in Denmark and Norway: Criteria Are Becoming Less Stringent

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy